ZN-c3 in Adult Participants With Metastatic Colorectal Cancer

Stopped Study terminated due to change in therapeutic landscape.

Conditions

• Metastatic Colorectal Cancer

Interventions

• DRUG: ZN-c3
• DRUG: Encorafenib
• DRUG: Cetuximab

Sponsor

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Collaborators

• [object Object]